These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23537934)

  • 1. Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models.
    Fauss D; Motter R; Dofiles L; Rodrigues MA; You M; Diep L; Yang Y; Seto P; Tanaka K; Baker J; Bergeron M
    J Neurosci Methods; 2013 May; 215(2):245-57. PubMed ID: 23537934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Kobayashi K; Takeuchi A; Yano A; Muraoka K; Matsui T; Miyoshi Y; Hamada H; Date I
    Eur J Neurosci; 2004 Mar; 19(6):1494-504. PubMed ID: 15066146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.
    Lu L; Zhao C; Liu Y; Sun X; Duan C; Ji M; Zhao H; Xu Q; Yang H
    Brain Res Brain Res Protoc; 2005 May; 15(1):46-51. PubMed ID: 15878150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice.
    Rothman SM; Griffioen KJ; Vranis N; Ladenheim B; Cong WN; Cadet JL; Haran J; Martin B; Mattson MP
    J Parkinsons Dis; 2013; 3(2):215-29. PubMed ID: 23938351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology.
    Nagatsu T
    Essays Biochem; 1995; 30():15-35. PubMed ID: 8822146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
    Charron G; Doudnikoff E; Laux A; Berthet A; Porras G; Canron MH; Barroso-Chinea P; Li Q; Qin C; Nosten-Bertrand M; Giros B; Delalande F; Van Dorsselaer A; Vital A; Goumon Y; Bezard E
    Brain; 2011 Aug; 134(Pt 8):2321-38. PubMed ID: 21742735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
    Decressac M; Pain S; Chabeauti PY; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A
    Neurobiol Aging; 2012 Sep; 33(9):2125-37. PubMed ID: 21816512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
    Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
    J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells].
    Huang Y; Chang C; Zhang JW; Gao XQ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2353-6. PubMed ID: 23158567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice--as a mouse model for Parkinson's disease.
    Takazawa C; Fujimoto K; Homma D; Sumi-Ichinose C; Nomura T; Ichinose H; Katoh S
    Biochem Biophys Res Commun; 2008 Mar; 367(4):787-92. PubMed ID: 18201550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic differentiation of human neural stem cells mediated by co-cultured rat striatal brain slices.
    Anwar MR; Andreasen CM; Lippert SK; Zimmer J; Martinez-Serrano A; Meyer M
    J Neurochem; 2008 Apr; 105(2):460-70. PubMed ID: 18194213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.